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Presence of Chimeric Maternally Derived
Keratinocytes in Cutaneous Inflammatory Diseases
of Children: The Example of Pityriasis Lichenoides
Kiarash Khosrotehrani1,2, Sarah Guegan2, Sylvie Fraitag3, Miche`le Oster2, Yves de Prost4,
Christine Bodemer4,5 and Selim Aractingi1,2,5
During pregnancy, maternal cells may enter the fetal circulation and persist until adulthood. The fate of these
cells remains unknown. As unexplained T-cell-mediated conditions such as pityriasis lichenoides (PL) may occur
in children, we aimed at identifying maternal cells in lesional skin of PL and controls. Archived skin biopsy
specimens from young males with PL, atopic dermatitis, or normal skin were scanned for the presence of female
(presumably maternal) cells using fluorescence in situ hybridization (FISH) with X and Y chromosome-specific
probes. Phenotyping of maternal cells relied on FISH combined with anti-CD45, anti-CD1a, or anti-cytokeratin
labelling, identifying leukocytes, Langerhans cells, and keratinocytes, respectively. Maternal cells were found in
PL (11/12) and controls (4/7), but their average frequency was higher in PL: 99 per million cells as compared to 5
per million cells in controls (P¼ 0.005). In the epidermis, the maternal microchimeric cells were labelled by anti-
cytokeratin in all cases. We identified maternally derived keratinocytes in the skin of male children with
inflammatory skin disorders. These cells may either help repair the damaged skin or home initially in the skin
and trigger a host (child) versus graft (mother) disease.
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INTRODUCTION
During pregnancy, cells of maternal origin enter the fetal
circulation as early as 13 weeks of gestation (Petit et al., 1997;
Lo et al., 1998). Beyond circulation, maternal chimeric cells
have been identified in various tissues from a small series of
newborn patients, such as thymus, liver, thyroid, and also skin
(Srivatsa et al., 2003). Interestingly, maternal cells can persist
until adult life up to 49 years (Maloney et al., 1999). The
consequences of this chimerism are currently under investi-
gation. Maternal and fetal cells are semi-allogenic. Therefore,
one hypothesis is that maternal cells may induce a reaction
against the child’s various tissues, triggering features of an
‘‘auto-immune’’ disease. In accordance, investigators have
reported the presence of maternal microchimeric cells in
lesional muscle and skin specimens of juvenile dermatomyo-
sitis, but not in controls (Artlett et al., 2000; Reed et al., 2000;
Selva-O’Callaghan et al., 2001). Maternal CD4þ cells have
been identified in the peripheral blood lymphocyte of juvenile
dermatomyositis patients (Artlett et al., 2000; Reed et al.,
2004). However, in the affected muscle, the precise type of
maternal infiltrating cells was not analyzed in these studies.
Similarly, adult patients affected with systemic sclerosis were
more prone for having maternal cell microchimerism in
their peripheral blood (Lambert et al., 2004). In contrast, in
the myocardium from foetuses with neonatal lupus syndrome,
maternally derived cardiomyocytes were identified (Stevens
et al., 2003). This unexpected result suggested that maternal
stem cells may have migrated to a damaged myocardium and
adopted a myocardial phenotype. This raises an alternate
hypothesis: maternal stem cells participate in the child’s tissue
regeneration process and do not trigger the disease.
Pityriasis lichenoides (PL) is an eruption of unknown
cause, characterized clinically by successive flares of
inflammatory skin lesions. The disease occurs more fre-
quently among children and young adults. Some investigators
have suggested that viral agents such as parvovirus B19
(Tomasini et al., 2004), varicella-zoster (Boralevi et al.,
2003), or Epstein–Barr virus (Klein et al., 2003) could initiate
these lesions. Pathological findings consist in a dermal peri-
vascular and peri-adnexial lymphocytic infiltration in wedge
shape, extending to the deep reticular dermis associated with
superficial erythrocytes extravasation. The epidermis shows
various levels of acanthosis, parakeratosis or scale-crusts,
usually housing nuclear debris, keratinocytic necrosis, and
exocytosis by a lymphocytic infiltrate of small size that can
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affect as well the adnexal epithelia or the hair follicles. The
lymphocytes have been characterized as mostly CD3þ ,
CD8þ , Tia1þ , cytotoxic T cells (Tomasini et al., 2004). All
these features may also be observed during the cutaneous
graft-versus-host disease. We therefore asked whether trans-
placentally transferred maternal cells could be identified as
allogenic cells in the skin of children affected with PL.
RESULTS
In skin biopsies of male children studied by fluorescence
in situ hybridization (FISH), the average estimated number of
scanned nucleated cells per patient was 145,000 among the
PL cases and 571,000 among the controls (P¼ 0.23) (Table 1).
Female cells were detected in 11/12 patients affected with PL
as compared with 4/7 controls (P¼0.15) (Figure 1). The
frequency of female microchimeric cells was 99 per million
cells in PL patients as compared to 5 per million cells in
controls (P¼ 0.005). Most microchimeric cells were detected
in the epidermis and only a few were in the dermis.
We next sought to determine the phenotype of maternal
microchimeric cells in the epidermis. In most cases studied,
the epidermis was infiltrated with leukocytes. We therefore
used CD45 to identify leukocytes, and CD1a and cytokeratin
to identify cell types that usually reside in the epidermis such
as Langerhans cells and keratinocytes. Combined FISH with
immunostaining using anti-CD45 antibody was used on nine
sections from patients affected with PL and five sections from
controls. None of the 19 microchimeric cells from the PL
patients stained positive with CD45. Similarly, on 10 sections
from PL patients and seven from the controls, none of the 20
microchimeric cells that were identified stained positively
with CD1a. However, using cytokeratin staining, seven out of
10 patients with PL had cytokeratin-positive epidermal
female cells. Overall, 14/21 microchimeric cells were
cytokeratin positive (Figure 2). The positive cells were located
exclusively in follicular or interfollicular epidermis. Most of
the female cells that did not stain with anti-cytokeratin
antibody were in the dermis.
DISCUSSION
The results of this study demonstrate the presence of
maternally derived cells in lesional skin of male children
presenting with inflammatory conditions, and more parti-
cularly in PL. Indeed, all the studied male children with PL
never had any transfusion, organ transplantation, or a twin
sister. Therefore, the female cells detected in this context were
most likely of maternal origin. Further on, phenotyping of these
maternal chimeric cells showed that these were keratinocytes,
as they expressed cytokeratin, but not CD45 and CD1a, and
were located almost exclusively in interfollicular or follicular
epidermis. Of note, the frequency of maternal cells was higher
in PL than in children with other inflammatory skin disorders.
Our study was performed using very stringent criteria for
determining the female genotype of cells (see Materials and
Methods). However, one cannot exclude that some XX cells
were in fact XY cells undergoing mitosis (XXYY) or aneuploid
cells. To overcome this problem, we used as controls
inflammatory skin diseases where the level of inflammation
Table 1. Patients affected with PL have higher
maternal cell microchimerism in their skin
Study
subjects
Average
number
of maternal
micro-
chimeric
cells/section
Number
of slides
examined
Frequency
of maternal
cells/million
total cells
Estimated
total
number
of cells
examined
PL1 3 2 222 27,000
PL2 2 2 160 25,000
PL3 1 2 96 20,800
PL4 1.5 3 21 289,880
PL5 0.5 4 40 50,400
PL6 0.5 2 156 6,400
PL7 0 3 0 130,200
PL8 3.25 4 62.5 208,000
PL9 2.5 4 312.5 32,000
PL10 1.25 4 9 532,000
PL11 2 4 25 316,400
PL12 3 3 89 100,800
INF1 0.5 2 7 141,600
INF2 0 2 0 142,000
INF3 0.33 3 17 58,980
INF4 0.33 3 7 138,000
INF5 0 3 0 79,200
HEALTHY1 0 3 0 2,290,920
HEALTHY2 0.33 3 0.87 1,145,460
PL1–12: male patients affected with PL; INF1–5: male patients affected
with eczema or drug reaction; HEALTHY1–2: healthy skin specimen from
male patients.
Figure 1. Maternal microchimeric cells are common in lesional skin from PL
patients. Photomicrographs show FISH experiments on paraffin-embedded
sections of skin biopsies from PL patients. We used hybridization probes to X
and Y chromosomes labelled respectively with Cy3 (red) and FITC (green).
All nuclei were counterstained with 40,6-diamidino-2-phenylindole (blue).
(a) Photomicrograph showing a female microchimeric XX cell (two red spots in
a single nucleus with intact borders; white arrow) in the epidermis surrounded
by male XY cells (black arrows indicate Y chromosomes). All chromosomes
may not appear in the same plane of focus due to the thickness of our sections
( 630 magnification). (b) Photomicrograph showing a female microchimeric
XX cell (two red spots in a single nucleus with intact borders; white arrow)
in the dermis. All chromosomes may not appear in the same plane of focus
due to the thickness of our sections. Original magnification:  630.
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was similar to our cases. Detecting maternal XX cells requires
that the nucleus be individualized. This is hardly achievable
in inflammatory areas where the cells are small and
overlapping. We therefore think that our study underesti-
mates the possibility that some microchimeric maternal cells
may express CD45. However, we believe that our analysis is
totally valid for the maternal cells found in the epidermis.
Previous reports have conclusively demonstrated the
presence of maternal microchimeric cells in the skin.
However, their phenotype was not studied and these may
also have been keratinocytes. Indeed, maternal cells have been
found in unaffected skin samples from autopsied newborns in
two out of four cases (Srivatsa et al., 2001). Similarly, in one
fetus affected with neonatal lupus syndrome and in young
patients affected with juvenile inflammatory myopathy,
maternal cell microchimerism has also been reported in the
skin (Artlett et al., 2000; Stevens et al., 2003). In the present
study, maternal cell chimerism could be identified in cases and
controls in lesional as well as in healthy skin although at a
much lower frequency. This difference in the frequency of
maternal microchimeric cells was not previously analyzed.
The fact that in inflammatory cutaneous conditions
occurring in children, chimeric cells appeared to be mainly
keratinocytes – rather than immune effector cells – is in
accordance with recent findings on lupus (Stevens et al.,
2003). In infants with neonatal lupus erythematosus, mater-
nally derived cells in the myocardium were indeed actin-
positive myocytes. This result in lupus –as well as ours in PL –
suggests that the maternally derived cells found in the
children’s damaged tissues are not immune effector cells
inducing a graft (mother) versus host (child) disease. Of note,
PL has never been associated with any HLA type I or type II
alleles. In contrast, these maternal cells appear to be tissue-
specific differentiated cells. These results suggest two
hypotheses: either the initial step is a primitive existence of
maternally derived keratinocytes in the healthy skin of
children. In this scheme, the higher density of such cells in
PL as compared to healthy skin could trigger a host versus
graft type inflammation. Alternatively, maternal stem cells
may specifically migrate to damaged skin, after the onset of
PL, in order to help repair. There may be a higher need for
this role in PL compared to other skin inflammatory disorders,
such as atopic dermatitis, because there is more epidermal
necrosis. Such phenomenon has already been suggested in
fetal cell microchimerism (Khosrotehrani et al., 2004).
Previous studies of bone marrow transplant recipients in
humans and animal models have demonstrated the possibility
of finding keratinocytes of donor origin (Korbling et al., 2002;
Borue et al., 2004; Harris et al., 2004). Therefore, our above
data as well as those of Stevens et al. suggest that under
pathologic conditions, maternal microchimeric cells can
adopt the child’s tissue phenotype in a neurectodermal and
mesodermal tissue. Maternally derived stem cells could
migrate to a damaged tissue and fuse or differentiate to
finally adopt the phenotype of keratinocytes or myocytes.
Whether the transferred maternal cells responsible for this
phenomenon are hemopoietic stem cells (Krause et al., 2001)
or another type remains unknown.
In conclusion, we identified maternally derived keratinocytes
in pediatric patients with inflammatory skin disorders, especially
PL. Further studies would need to investigate whether mater-
nally derived cells contribute to the disease or help repairing it.
MATERIALS AND METHODS
Patients
We retrieved routine archival paraffin-embedded lesional skin
biopsies from 12 male children affected with PL (aged 2–13 years,
average 7.2 years) and five male children with other inflammatory
skin disorders (four atopic dermatitis and one cutaneous drug
reaction) according to local ethical committee procedures with
regard to the Helsinki guidelines and patient consent. All PL patients
were diagnosed with PL chronica on the basis of a histological
examination of a lesional skin biopsy. In addition, two healthy
cutaneous specimens adjacent to congenital naevi surgical pieces
Figure 2. Microchimeric maternal cells in the epidermis express cytokeratin.
Photomicrographs show combined FISH and immunostaining experiments.
We used hybridization probes to X and Y chromosomes labelled respectively
with Cy3 (red) and FITC (green). All nuclei were counterstained with 40,
6-diamidino-2-phenylindole (blue). (a) CD45-positive (3-amino-9-ethylcarba-
zole substrate for CD45 staining in red; black arrows) male cells adjacent to a
microchimeric female cell that was not stained with anti-CD45 antibody.
(b) CD1a-positive (3-amino-9-ethylcarbazole substrate for CD1a staining in
red; black arrow) male cell adjacent to a microchimeric female cell that was
not stained with anti-CD1a antibody. (c, d) Cytokeratin-expressing (revealed
by FITC-labelled secondary antibody in green) microchimeric cells in the
epidermis. The morphology is highly suggestive of keratinocytes. (e) Micro-
chimeric cell in the epidermal layers of a hair follicle. (f) Same microchimeric
cell stained with cytokeratin (green) showing a keratinocyte phenotype.
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were obtained. All patients and controls were male, without any
history of transfusion or being a twin.
Fluorescence in situ hybridization
FISH was performed as previously described (Johnson et al., 2000)
on 5-mm-thick paraffin-embedded sections. We used X and Y
chromosome probes labelled respectively with Cy3 (red) and FITC
(green) mapping to Xp11.1q11.1 – a satellite centromeric region of
the X chromosome – and Yq12 satellite III region of the Y
chromosome (Vysis, Downers Grove, IL).
Combined FISH with immunostaining
We combined FISH and immunostaining as previously described
(Khosrotehrani et al., 2003, 2004). The antibodies used were
anti-CD45, anti-CD1a (Dako, Carpintera, CA), and anti-cytokeratin
antibodies (Chemicon International, Temecula, CA) that stain leuko-
cytes, Langerhans cells, and keratinocytes or other epithelial cells,
respectively. Staining was revealed by the Envisionþ peroxidase
kit (Dako) for CD1a and CD45. For cytokeratin labelling, we
used immunofluorescence with secondary goat anti-mouse anti-
body labelled with fluorescein (Jackson ImmunoResearch, West
Grove, PA). All slides were counterstained with 40,6-diamidino-2-
phenylindole.
Scoring and statistical analysis
Sections from male patients and controls were all blindly scanned for
the presence of female – presumably maternal – cells. Sections were
scored if more than 70% of the nuclei had at least one FISH signal.
Male cells were recognized as having one X (red) and one Y (green)
chromosome. In order to conclusively identify a female cell, the
following criteria were requested: (1) presence of two red signals
corresponding to the size and shape of adjacent X chromosomes
inside a blue-colored nucleus; (2) presence of a minimal distance
between the two signals corresponding to at least the size of one
of them; (3) presence of intact and recognizable nuclear borders;
(4) absence of overlapping nuclei; and (5) absence of a Y chromo-
some FISH signal (green). When all these criteria were fulfilled, the
cell was considered as microchimeric and counted. Within each
section, we estimated the total number of nucleated cells: the
number of nuclei in three fields ( 630 magnification) in the dermis
and the number of nuclei in three fields in the epidermis were
counted separately. The total number of epidermal nuclei and
dermal nuclei per section was obtained by multiplying the mean
nuclei count per field of each skin layer with the number of fields in
the dermis and the epidermis. This was the denominator for each
section, provided in the last column of Table 1.
For each case, the number of microchimeric cells found was
adjusted to the total number of cells examined. The average
frequency of microchimeric cells was then compared in the PL
and the control group using Student’s t-test.
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